Search Results for: PDE4DIP

95 interactions involving PDE4DIP - phosphodiesterase 4D interacting protein found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
PFDN1 prefoldin subunit 1
  • Prefoldin mediated transfer of substrate to CCT/TriC
PIAS4 protein inhibitor of activated STAT 4
  • Vitamin D (calciferol) metabolism
  • SUMOylation of DNA damage response and repair proteins
  • SUMOylation of transcription factors
  • SUMOylation of ubiquitinylation proteins
  • SUMOylation of transcription cofactors
  • SUMOylation of SUMOylation proteins
  • SUMOylation of intracellular receptors
  • SUMOylation of intracellular receptors
  • SUMOylation of DNA replication proteins
  • SUMOylation of immune response proteins
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Nonhomologous End-Joining (NHEJ)
  • Processing of DNA double-strand break ends
  • G2/M DNA damage checkpoint
PPP1R18 protein phosphatase 1 regulatory subunit 18
PRNP prion protein
  • NCAM1 interactions
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Tetracycline
  • Copper
  • Prion diseases; Creutzfeldt-Jacob disease (CJD); Gerstmann-Straussler disease (GSD); Gerstmann-Straussler-Scheinker disease (GSSD); Fatal familial insomnia (FFI)
PRPF31 pre-mRNA processing factor 31
  • mRNA Splicing - Major Pathway
  • Retinitis pigmentosa (RP)
PYGM glycogen phosphorylase, muscle associated
  • Glycogen breakdown (glycogenolysis)
  • Glycogen breakdown (glycogenolysis)
  • Pyridoxal phosphate
  • Beta-D-Glucopyranose Spirohydantoin
  • (5S,7R,8S,9S,10R)-3-Amino-8,9,10-trihydroxy-7-(hydroxymethyl)-6-oxa-1,3-diazaspiro[4.5]decane-2,4-dione
  • alpha-D-glucose 6-phosphate
  • N-beta-D-glucopyranosylacetamide
  • Monofluorophosphate ion
  • Beta-D-Glucose
  • 3,8,9,10-tetrahydroxy-7-hydroxymethyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione
  • Nojirimycine Tetrazole
  • Indirubin-5-sulphonate
  • 2-Deoxy-Glucose-6-Phosphate
  • C-(1-hydrogyl-beta-D-glucopyranosyl) formamide
  • alpha-D-glucopyranosyl-2-carboxylic acid amide
  • alpha-D-glucose-1-phosphate
  • 8,9,10-Trihydroxy-7-hydroxymethyl-2-thioxo-6-oxa-1,3-diaza-spiro[4.5]decan-4-one
  • 4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid
  • 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole
  • N-acetyl-N'-beta-D-glucopyranosyl urea
  • 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole
  • C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide
  • 2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole
  • CP-320626
  • (3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester
  • 8,9,10-trihydroxy-7-hydroxymethyl-3-methyl-6-oxa-1,3-diaza-spiro[4.5]decane-2,4-dione
  • Alvocidib
  • 1-deoxy-1-methoxycarbamido-beta-D-glucopyranose
  • N-[(5S,7R,8S,9S,10R)-8,9,10-Trihydroxy-7-(hydroxymethyl)-2,4-dioxo-6-oxa-1,3-diazaspiro[4.5]dec-3-yl]acetamide
  • 1-Deoxy-1-methoxycarbamido-beta-D-gluco-2-heptulopyranosonamide
  • 4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid
  • 2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium
  • N(6)-(pyridoxal phosphate)-L-lysine
  • Heptulose-2-Phosphate
  • N-(Benzoylcarbamoyl)-beta-D-glucopyranosylamine
  • Dexfosfoserine
  • 1-Deoxy-1-acetylamino-beta-D-gluco-2-heptulopyranosonamide
  • Inosinic Acid
  • 7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID
  • 4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID
  • 4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID
  • 5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID
  • 2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
  • 2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
  • (S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
  • (2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE
  • (3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL
  • ({[(3E)-2'-Oxo-2',7'-dihydro-2,3'-biindol-3(7H)-ylidene]amino}oxy)acetic acid
  • (5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol
  • 2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID
  • (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol
  • (3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol
  • Glycogen storage diseases (GSD), including: von Gierke disease (GSD type Ia); Pompe disease (GSD type II); Cori disease, Forbe disease (GSD type III); Andersen disease (GSD type IV); McArdle disease (GSD type V); Hers disease (GSD type VI); Tarui disease (GSD type VII); Phosphorylase kinase deficiency (GSD type IX); Fanconi-Bickel syndrome (GSD type XI); Glycogen synthase deficiency (GSD type 0)
RTP5 receptor transporter protein 5 (putative)
  • Olfactory Signaling Pathway
SCNM1 sodium channel modifier 1
SDCBP syndecan binding protein
  • Ephrin signaling
  • Neurofascin interactions
  • RIPK1-mediated regulated necrosis
  • Regulation of necroptotic cell death
  • Neutrophil degranulation
SH2D4A SH2 domain containing 4A
SHFL shiftless antiviral inhibitor of ribosomal frameshifting
SMN1 survival of motor neuron 1, telomeric
  • snRNP Assembly
  • Nusinersen
  • Spinal muscular atrophy (SMA), including: SMA type I (SMA1) / Werdning-Hoffman disease; SMA type II (SMA2); SMA type III (SMA3) / Kugeleberg-Welander disease; SMA type IV (SMA4); X-linked SMA 2 (SMAX2); X-linked distal SMA 3 (DSMAX); Distal SMA autosomal recessive type 4 (DSMA4); Congenital distal spinal muscular atrophy (SMAL); SMA proximal adult autosomal dominant (SMAPAD)
SNCA synuclein alpha
  • Amyloid fiber formation
  • Resveratrol
  • Copper
  • Lewy body dementia (LBD); Dementia with Lewy bodies (DLB)
  • Parkinson's disease (PD)
TEAD4 TEA domain transcription factor 4
  • YAP1- and WWTR1 (TAZ)-stimulated gene expression
  • RUNX3 regulates YAP1-mediated transcription
TFIP11 tuftelin interacting protein 11
  • mRNA Splicing - Major Pathway
TK1 thymidine kinase 1
  • G1/S-Specific Transcription
  • Pyrimidine salvage
  • Dithioerythritol
  • Thymidine 5'-triphosphate
TNIK TRAF2 and NCK interacting kinase
  • Oxidative Stress Induced Senescence
  • Fostamatinib
TRAF4 TNF receptor associated factor 4
TULP3 TUB like protein 3
  • Hedgehog 'off' state
UTP14C UTP14C small subunit processome component
  • rRNA modification in the nucleus and cytosol
  • Major pathway of rRNA processing in the nucleolus and cytosol

Page 4 out of 5 pages